Browsing by Author "Sharlaa Badal-Faesen"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item A Standardized Approach for Collection of Objective Data to Support Outcome Determination for LatePhase Tuberculosis Clinical Trials(AMER THORACIC SOC) Ekaterina V. Kurbatova; Patrick P.J. Phillips; Susan E. Dorman; Erin E. Sizemore; E et al; Sharlaa Badal-Faesen; Ziyaad WajaItem Thirdline antiretroviral therapy including raltegravir RAL darunavir DRVr andor etravirine ETR is well tolerated and achieves durable virologic suppression over 144 weeks in resourcelimited settings ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Sharlaa Badal-Faesen; Lerato Mohapi; E et al